Search

Takeda Pharmaceutical - Implantable Cell Chamber Device, EP4120958A1

The European Patent Office granted Takeda Pharmaceutical Company Limited Patent EP4120958A1 titled 'Implantable Cell Chamber Device and Uses Thereof,' published April 15, 2026. The patent application (filed by inventors LING, Vincent, IMAICHI, Sachiko, PHANEUF, Matthew, LONG, Nathaniel, KASSAB, Rayan, and ROBERTSON, Robbie James) covers technology related to implantable cell chamber devices and their therapeutic applications, with IPC classifications spanning prosthetics (A61F), biomedical materials (A61L), and therapeutic agents (A61P) including gastrointestinal applications. The patent is designated across 31 European member states including Germany, France, the United Kingdom, Italy, Spain, the Netherlands, Belgium, Austria, and Switzerland.

Piperidinyl Aryloxy Propanamides and Propanoates Patent EP3759094A1

The European Patent Office published patent application EP3759094A1 for Takeda Pharmaceutical Company Limited covering piperidinyl-3-(aryloxy)propanamides and propanoates compounds. The patent application includes therapeutic indications for depression (A61P 25/24), CNS disorders (A61P 25/28), and psychiatric disorders (A61P 25/18). The application designates multiple European states including Germany, France, United Kingdom, Italy, Spain, and others.